메뉴 건너뛰기




Volumn 41, Issue 6, 2008, Pages 1095-1106

Imaging of Recurrent Thyroid Cancer

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE 123; IODINE 131; TETROFOSMIN TC 99M; THALLIUM 201; THYROGLOBULIN;

EID: 56449096466     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2008.05.003     Document Type: Review
Times cited : (17)

References (43)
  • 1
    • 0032535770 scopus 로고    scopus 로고
    • A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995
    • [see comments]
    • Hundahl S.A., Fleming I.D., Fremgen A.M., et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. [see comments]. Cancer 83 12 (1998) 2638-2648
    • (1998) Cancer , vol.83 , Issue.12 , pp. 2638-2648
    • Hundahl, S.A.1    Fleming, I.D.2    Fremgen, A.M.3
  • 2
    • 0031028402 scopus 로고    scopus 로고
    • Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991
    • Gilliland F.D., Hunt W.C., Morris D.M., et al. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 79 3 (1997) 564-573
    • (1997) Cancer , vol.79 , Issue.3 , pp. 564-573
    • Gilliland, F.D.1    Hunt, W.C.2    Morris, D.M.3
  • 3
    • 33646442046 scopus 로고    scopus 로고
    • Increasing incidence of thyroid cancer in the United States, 1973-2002
    • Davies L., and Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295 18 (2006) 2164-2167
    • (2006) JAMA , vol.295 , Issue.18 , pp. 2164-2167
    • Davies, L.1    Welch, H.G.2
  • 4
    • 85047681191 scopus 로고    scopus 로고
    • Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer
    • Mazzaferri E.L., and Kloos R.T. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86 4 (2001) 1447-1463
    • (2001) J Clin Endocrinol Metab , vol.86 , Issue.4 , pp. 1447-1463
    • Mazzaferri, E.L.1    Kloos, R.T.2
  • 5
    • 0024232116 scopus 로고
    • An expanded view of risk-group definition in differentiated thyroid carcinoma
    • Cady B., and Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104 6 (1988) 947-953
    • (1988) Surgery , vol.104 , Issue.6 , pp. 947-953
    • Cady, B.1    Rossi, R.2
  • 6
    • 0037003313 scopus 로고    scopus 로고
    • Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin
    • Mazzaferri E.L., and Massoll N. Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin. Endocr Relat Cancer 9 4 (2002) 227-247
    • (2002) Endocr Relat Cancer , vol.9 , Issue.4 , pp. 227-247
    • Mazzaferri, E.L.1    Massoll, N.2
  • 7
    • 3242693043 scopus 로고    scopus 로고
    • Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases
    • Torlontano M., Attard M., Crocetti U., et al. Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab 89 7 (2004) 3402-3407
    • (2004) J Clin Endocrinol Metab , vol.89 , Issue.7 , pp. 3402-3407
    • Torlontano, M.1    Attard, M.2    Crocetti, U.3
  • 8
    • 34548046458 scopus 로고    scopus 로고
    • Will highly sensitive thyroglobulin assays change the management of thyroid cancer?
    • Mazzaferri E.L. Will highly sensitive thyroglobulin assays change the management of thyroid cancer?. Clin Endocrinol (Oxf) 67 3 (2007) 321-323
    • (2007) Clin Endocrinol (Oxf) , vol.67 , Issue.3 , pp. 321-323
    • Mazzaferri, E.L.1
  • 9
    • 0019777718 scopus 로고
    • The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer
    • Ashcraft M.W., and Van Herle A.J. The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer. Am J Med 71 5 (1981) 806-814
    • (1981) Am J Med , vol.71 , Issue.5 , pp. 806-814
    • Ashcraft, M.W.1    Van Herle, A.J.2
  • 10
    • 0028049352 scopus 로고
    • Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma
    • Lubin E., Mechlis-Frish S., Zatz S., et al. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma. J Nucl Med 35 2 (1994) 257-262
    • (1994) J Nucl Med , vol.35 , Issue.2 , pp. 257-262
    • Lubin, E.1    Mechlis-Frish, S.2    Zatz, S.3
  • 11
    • 24344489445 scopus 로고    scopus 로고
    • A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later
    • Kloos R.T., and Mazzaferri E.L. A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. J Clin Endocrinol Metab 90 9 (2005) 5047-5057
    • (2005) J Clin Endocrinol Metab , vol.90 , Issue.9 , pp. 5047-5057
    • Kloos, R.T.1    Mazzaferri, E.L.2
  • 12
    • 0027243685 scopus 로고
    • Fine-needle biopsy of cervical lymph nodes in patients with thyroid cancer: a prospective comparison of cytopathologic and tissue marker analysis
    • Lee M.J., Ross D.S., Mueller P.R., et al. Fine-needle biopsy of cervical lymph nodes in patients with thyroid cancer: a prospective comparison of cytopathologic and tissue marker analysis. Radiology 187 3 (1993) 851-854
    • (1993) Radiology , vol.187 , Issue.3 , pp. 851-854
    • Lee, M.J.1    Ross, D.S.2    Mueller, P.R.3
  • 13
    • 0035948197 scopus 로고    scopus 로고
    • Ultrasound-guided fine-needle aspiration biopsy of the thyroid bed
    • Krishnamurthy S., Bedi D.G., and Caraway N.P. Ultrasound-guided fine-needle aspiration biopsy of the thyroid bed. Cancer 93 3 (2001) 199-205
    • (2001) Cancer , vol.93 , Issue.3 , pp. 199-205
    • Krishnamurthy, S.1    Bedi, D.G.2    Caraway, N.P.3
  • 14
    • 0033674689 scopus 로고    scopus 로고
    • Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma
    • Frilling A., Gorges R., Tecklenborg K., et al. Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma. Surgery 128 6 (2000) 1067-1074
    • (2000) Surgery , vol.128 , Issue.6 , pp. 1067-1074
    • Frilling, A.1    Gorges, R.2    Tecklenborg, K.3
  • 15
    • 0036280909 scopus 로고    scopus 로고
    • Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment
    • Pacini F., Capezzone M., Elisei R., et al. Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab 87 4 (2002) 1499-1501
    • (2002) J Clin Endocrinol Metab , vol.87 , Issue.4 , pp. 1499-1501
    • Pacini, F.1    Capezzone, M.2    Elisei, R.3
  • 16
    • 34447622455 scopus 로고    scopus 로고
    • Followup of patients with papillary thyroid cancer: in search of the optimal algorithm
    • Mittendorf E.A., Wang X., Perrier N.D., et al. Followup of patients with papillary thyroid cancer: in search of the optimal algorithm. J Am Coll Surg 205 2 (2007) 239-247
    • (2007) J Am Coll Surg , vol.205 , Issue.2 , pp. 239-247
    • Mittendorf, E.A.1    Wang, X.2    Perrier, N.D.3
  • 17
    • 0036281001 scopus 로고    scopus 로고
    • Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
    • Mazzaferri E.L., and Kloos R.T. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?. J Clin Endocrinol Metab 87 4 (2002) 1490-1498
    • (2002) J Clin Endocrinol Metab , vol.87 , Issue.4 , pp. 1490-1498
    • Mazzaferri, E.L.1    Kloos, R.T.2
  • 18
    • 0032589873 scopus 로고    scopus 로고
    • Non-131I-scintigraphy in the treatment and follow-up of thyroid cancer. Single-photon-emitters or FDG-PET?
    • Grunwald F., Briele B., and Biersack H.J. Non-131I-scintigraphy in the treatment and follow-up of thyroid cancer. Single-photon-emitters or FDG-PET?. Q J Nucl Med 43 3 (1999) 195-206
    • (1999) Q J Nucl Med , vol.43 , Issue.3 , pp. 195-206
    • Grunwald, F.1    Briele, B.2    Biersack, H.J.3
  • 19
    • 0025005762 scopus 로고
    • Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?
    • Ronga G., Fiorentino A., Paserio E., et al. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?. J Nucl Med 31 11 (1990) 1766-1771
    • (1990) J Nucl Med , vol.31 , Issue.11 , pp. 1766-1771
    • Ronga, G.1    Fiorentino, A.2    Paserio, E.3
  • 20
    • 0031742512 scopus 로고    scopus 로고
    • Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases
    • Unal S., Menda Y., Adalet I., et al. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases. J Nucl Med 39 11 (1998) 1897-1902
    • (1998) J Nucl Med , vol.39 , Issue.11 , pp. 1897-1902
    • Unal, S.1    Menda, Y.2    Adalet, I.3
  • 21
    • 0031893404 scopus 로고    scopus 로고
    • Thallium-201 uptake with negative iodine-131 scintigraphy and serum thyroglobulin in metastatic oxyphilic papillary thyroid carcinoma
    • Harder W., Lind P., Molnar M., et al. Thallium-201 uptake with negative iodine-131 scintigraphy and serum thyroglobulin in metastatic oxyphilic papillary thyroid carcinoma. J Nucl Med 39 2 (1998) 236-238
    • (1998) J Nucl Med , vol.39 , Issue.2 , pp. 236-238
    • Harder, W.1    Lind, P.2    Molnar, M.3
  • 22
    • 0031966884 scopus 로고    scopus 로고
    • Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma
    • Gallowitsch H.J., Mikosch P., Kresnik E., et al. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma. J Nucl Med 39 5 (1998) 870-875
    • (1998) J Nucl Med , vol.39 , Issue.5 , pp. 870-875
    • Gallowitsch, H.J.1    Mikosch, P.2    Kresnik, E.3
  • 23
    • 30344488437 scopus 로고    scopus 로고
    • Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy
    • Torlontano M., Crocetti U., Augello G., et al. Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy. J Clin Endocrinol Metab 91 1 (2006) 60-63
    • (2006) J Clin Endocrinol Metab , vol.91 , Issue.1 , pp. 60-63
    • Torlontano, M.1    Crocetti, U.2    Augello, G.3
  • 24
    • 0023099793 scopus 로고
    • Sonography in the follow-up of 100 patients with thyroid carcinoma
    • Simeone J.F., Daniels G.H., Hall D.A., et al. Sonography in the follow-up of 100 patients with thyroid carcinoma. AJR Am J Roentgenol 148 1 (1987) 45-49
    • (1987) AJR Am J Roentgenol , vol.148 , Issue.1 , pp. 45-49
    • Simeone, J.F.1    Daniels, G.H.2    Hall, D.A.3
  • 25
    • 0037216216 scopus 로고    scopus 로고
    • Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma
    • Frasoldati A., Pesenti M., Gallo M., et al. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 97 1 (2003) 90-96
    • (2003) Cancer , vol.97 , Issue.1 , pp. 90-96
    • Frasoldati, A.1    Pesenti, M.2    Gallo, M.3
  • 26
    • 0023808716 scopus 로고
    • US-guided biopsy of neck masses in postoperative management of patients with thyroid cancer
    • Sutton R.T., Reading C.C., Charboneau J.W., et al. US-guided biopsy of neck masses in postoperative management of patients with thyroid cancer. Radiology 168 3 (1988) 769-772
    • (1988) Radiology , vol.168 , Issue.3 , pp. 769-772
    • Sutton, R.T.1    Reading, C.C.2    Charboneau, J.W.3
  • 27
    • 0031434133 scopus 로고    scopus 로고
    • High-resolution ultrasound associated with aspiration biopsy in the follow-up of patients with differentiated thyroid cancer
    • Rodriguez J.M., Reus M., Moreno A., et al. High-resolution ultrasound associated with aspiration biopsy in the follow-up of patients with differentiated thyroid cancer. Otolaryngol Head Neck Surg 117 6 (1997) 694-697
    • (1997) Otolaryngol Head Neck Surg , vol.117 , Issue.6 , pp. 694-697
    • Rodriguez, J.M.1    Reus, M.2    Moreno, A.3
  • 28
    • 0033405775 scopus 로고    scopus 로고
    • Fluorine-18 fluorodeoxyglucose dual-head positron emission tomography in the detection of recurrent differentiated thyroid cancer: preliminary results
    • Stokkel M.P., de Klerk J.H., Zelissen P.M., et al. Fluorine-18 fluorodeoxyglucose dual-head positron emission tomography in the detection of recurrent differentiated thyroid cancer: preliminary results. Eur J Nucl Med 26 12 (1999) 1606-1609
    • (1999) Eur J Nucl Med , vol.26 , Issue.12 , pp. 1606-1609
    • Stokkel, M.P.1    de Klerk, J.H.2    Zelissen, P.M.3
  • 29
    • 34047214644 scopus 로고    scopus 로고
    • 18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer
    • Shammas A., Degirmenci B., Mountz J.M., et al. 18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer. J Nucl Med 48 2 (2007) 221-226
    • (2007) J Nucl Med , vol.48 , Issue.2 , pp. 221-226
    • Shammas, A.1    Degirmenci, B.2    Mountz, J.M.3
  • 30
    • 0036009138 scopus 로고    scopus 로고
    • Implication of 2-18fluor-2-deoxyglucose positron emission tomography in the follow-up of Hurthle cell thyroid cancer
    • Plotkin M., Hautzel H., Krause B.J., et al. Implication of 2-18fluor-2-deoxyglucose positron emission tomography in the follow-up of Hurthle cell thyroid cancer. Thyroid 12 2 (2002) 155-161
    • (2002) Thyroid , vol.12 , Issue.2 , pp. 155-161
    • Plotkin, M.1    Hautzel, H.2    Krause, B.J.3
  • 31
    • 13444301390 scopus 로고    scopus 로고
    • The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma
    • Nahas Z., Goldenberg D., Fakhry C., et al. The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma. Laryngoscope 115 2 (2005) 237-243
    • (2005) Laryngoscope , vol.115 , Issue.2 , pp. 237-243
    • Nahas, Z.1    Goldenberg, D.2    Fakhry, C.3
  • 32
    • 4444366490 scopus 로고    scopus 로고
    • The clinical impact of 18F-FDG gamma PET in patients with recurrent well differentiated thyroid carcinoma
    • Goshen E., Cohen O., Rotenberg G., et al. The clinical impact of 18F-FDG gamma PET in patients with recurrent well differentiated thyroid carcinoma. Nucl Med Commun 24 9 (2003) 959-961
    • (2003) Nucl Med Commun , vol.24 , Issue.9 , pp. 959-961
    • Goshen, E.1    Cohen, O.2    Rotenberg, G.3
  • 33
    • 0035209518 scopus 로고    scopus 로고
    • Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma
    • Frilling A., Tecklenborg K., Gorges R., et al. Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma. Ann Surg 234 6 (2001) 804-811
    • (2001) Ann Surg , vol.234 , Issue.6 , pp. 804-811
    • Frilling, A.1    Tecklenborg, K.2    Gorges, R.3
  • 34
    • 0032871248 scopus 로고    scopus 로고
    • Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography
    • Conti P.S., Durski J.M., Bacqai F., et al. Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography. Thyroid 9 8 (1999) 797-804
    • (1999) Thyroid , vol.9 , Issue.8 , pp. 797-804
    • Conti, P.S.1    Durski, J.M.2    Bacqai, F.3
  • 35
    • 33745429077 scopus 로고    scopus 로고
    • Role of [18F]fluorodeoxyglucose positron emission tomography in follow-up of differentiated thyroid cancer
    • Alzahrani A.S., Mohamed G.E., Al Rifai A., et al. Role of [18F]fluorodeoxyglucose positron emission tomography in follow-up of differentiated thyroid cancer. Endocr Pract 12 2 (2006) 152-158
    • (2006) Endocr Pract , vol.12 , Issue.2 , pp. 152-158
    • Alzahrani, A.S.1    Mohamed, G.E.2    Al Rifai, A.3
  • 36
    • 0034130683 scopus 로고    scopus 로고
    • FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma
    • Alnafisi N.S., Driedger A.A., Coates G., et al. FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma. J Nucl Med 41 6 (2000) 1010-1015
    • (2000) J Nucl Med , vol.41 , Issue.6 , pp. 1010-1015
    • Alnafisi, N.S.1    Driedger, A.A.2    Coates, G.3
  • 37
    • 33646205501 scopus 로고    scopus 로고
    • The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literature
    • Stokkel M.P., Duchateau C.S., and Dragoiescu C. The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literature. Q J Nucl Med Mol Imaging 50 1 (2006) 78-87
    • (2006) Q J Nucl Med Mol Imaging , vol.50 , Issue.1 , pp. 78-87
    • Stokkel, M.P.1    Duchateau, C.S.2    Dragoiescu, C.3
  • 38
    • 32544437659 scopus 로고    scopus 로고
    • Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning
    • Robbins R.J., Wan Q., Grewal R.K., et al. Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. J Clin Endocrinol Metab 91 2 (2006) 498-505
    • (2006) J Clin Endocrinol Metab , vol.91 , Issue.2 , pp. 498-505
    • Robbins, R.J.1    Wan, Q.2    Grewal, R.K.3
  • 39
    • 0037849895 scopus 로고    scopus 로고
    • A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma
    • Mazzaferri E.L., Robbins R.J., Spencer C.A., et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88 4 (2003) 1433-1441
    • (2003) J Clin Endocrinol Metab , vol.88 , Issue.4 , pp. 1433-1441
    • Mazzaferri, E.L.1    Robbins, R.J.2    Spencer, C.A.3
  • 40
    • 33745684505 scopus 로고    scopus 로고
    • European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
    • Pacini F., Schlumberger M., Dralle H., et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154 6 (2006) 787-803
    • (2006) Eur J Endocrinol , vol.154 , Issue.6 , pp. 787-803
    • Pacini, F.1    Schlumberger, M.2    Dralle, H.3
  • 41
    • 33645465719 scopus 로고    scopus 로고
    • Management guidelines for patients with thyroid nodules and differentiated thyroid cancer
    • Cooper D.S., Doherty G.M., Haugen B.R., et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16 2 (2006) 109-142
    • (2006) Thyroid , vol.16 , Issue.2 , pp. 109-142
    • Cooper, D.S.1    Doherty, G.M.2    Haugen, B.R.3
  • 42
    • 33846437453 scopus 로고    scopus 로고
    • The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers
    • Leboulleux S., Schroeder P.R., Schlumberger M., et al. The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers. Nat Clin Pract Endocrinol Metab 3 2 (2007) 112-121
    • (2007) Nat Clin Pract Endocrinol Metab , vol.3 , Issue.2 , pp. 112-121
    • Leboulleux, S.1    Schroeder, P.R.2    Schlumberger, M.3
  • 43
    • 24044476177 scopus 로고    scopus 로고
    • Papillary thyroid cancer: medical management and follow-up
    • Kloos R.T. Papillary thyroid cancer: medical management and follow-up. Curr Treat Options Oncol 6 4 (2005) 323-338
    • (2005) Curr Treat Options Oncol , vol.6 , Issue.4 , pp. 323-338
    • Kloos, R.T.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.